Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

13.65
+0.58004.44%
Volume:10.04K
Turnover:135.10K
Market Cap:201.01M
PE:-1.38
High:13.73
Open:13.14
Low:13.14
Close:13.07
52wk High:55.89
52wk Low:5.20
Shares:14.73M
Float Shares:10.47M
Volume Ratio:1.04
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.8800
EPS(LYR):-12.4806
ROE:-97.69%
ROA:-27.95%
PB:1.95
PE(LYR):-1.09

Loading ...

Korro Bio Director Jean Francois Formela Disposes of 28,468 Common Shares for $398,552

Reuters
·
Aug 22

Korro Bio Price Target Maintained with a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 20

Korro Bio Advances KRRO-121 Into First Human Trial

TIPRANKS
·
Aug 20

Korro Bio Submits Ethics Review Request in Australia for KRRO-121 First-in-Human Trial

Reuters
·
Aug 20

Korro Bio Grants New Hire Stock Option for 600 Shares at USD 13.35 Each

Reuters
·
Aug 15

Korro Bio Director Jean Francois Formela Reports $29,922 Disposal of Common Shares

Reuters
·
Aug 14

Lynx1 Capital Reports $78,648 Korro Bio Common Shares Purchase

Reuters
·
Aug 13

Korro Bio, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Korro Bio, Inc. Expected to Post a Loss of $1.43 a Share - Earnings Preview

Reuters
·
Aug 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Korro Bio (KRRO), Electrocore (ECOR) and BioLife Solutions (BLFS)

TIPRANKS
·
Aug 07

Korro Bio Q2 EPS $(1.07) Beats $(1.31) Estimate

Benzinga Earnings
·
Aug 06

Korro Bio Publishes Corporate Deck Outlining RNA-Editing Pipeline for Hyperammonemia and Alpha-1 Antitrypsin Deficiency

Reuters
·
Aug 06

Korro Bio Q2 FY26 Net Loss Narrows to USD 18.92 Million; Revenue Posts no Collaboration Revenue

Reuters
·
Aug 06

Korro Bio, - Q2 2026 Net Loss $18.90 Mln

THOMSON REUTERS
·
Aug 06

Korro Bio Grants Stock Options for 23,000 Shares to Seven New Hires Under Inducement Plan

Reuters
·
Jul 11

Korro Bio Director Jean Francois Formela Reports Disposal of Common Shares Worth $1.53 Million

Reuters
·
Jul 08

Korro Bio Director Jean Francois Formela Disposes of USD 2.47 Million in Common Shares

Reuters
·
Jun 25

Will Korro Bio (NASDAQ:KRRO) Spend Its Cash Wisely?

Simply Wall St.
·
Jun 16

Korro Bio shareholders elect Bermingham, Meyers as Class I directors at annual meeting

Reuters
·
Jun 12

Korro Bio director Jean Francois Formela disposes of 2,860 common shares worth $39,897‬

Reuters
·
Jun 02